Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

"Comparison of of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes in Laparoscopic Cholecystectomy" (VCV VS PCV)

9. november 2026 oppdatert av: Mehreen Mirza

"Comparison of the Effects of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes on Compliance and End-Tidal CO2 In Patients Undergoing Laparoscopic Cholecystectomy"

This randomized controlled trial compares volume-controlled ventilation and pressure-controlled ventilation in adult patients undergoing elective laparoscopic cholecystectomy under general anesthesia. The study evaluates the effects of both ventilation modes on static lung compliance and end-tidal carbon dioxide at predefined intraoperative time points. The objective is to determine whether pressure-controlled ventilation provides improved respiratory mechanics and more effective ventilation compared with volume-controlled ventilation during laparoscopic surgery.

Studieoversikt

Detaljert beskrivelse

Laparoscopic cholecystectomy is commonly performed under general anesthesia with carbon dioxide pneumoperitoneum. Increased intra-abdominal pressure during pneumoperitoneum can alter respiratory mechanics, reduce lung compliance, and increase airway pressures. These physiological changes may affect ventilation and gas exchange during laparoscopic procedures.

This randomized controlled trial is designed to compare two commonly used mechanical ventilation strategies: volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). Participants are randomly allocated in a 1:1 ratio to receive either ventilation mode during elective laparoscopic cholecystectomy. A standardized general anesthetic technique and consistent intraoperative ventilation targets are maintained in both groups to minimize variations in perioperative management.

In the VCV group, ventilation is delivered using a preset tidal volume, whereas in the PCV group, inspiratory pressure is adjusted to achieve the target tidal volume. The ventilation protocol includes a tidal volume of 8 mL/kg, an initial respiratory rate of 12 breaths per minute with subsequent adjustment according to end-tidal carbon dioxide levels, an inspiratory-to-expiratory ratio of 1:2, a positive end-expiratory pressure (PEEP) of 5 cmH₂O, and an inspired oxygen concentration (FiO₂) of 40%.

Intraoperative respiratory parameters, including static lung compliance and end-tidal carbon dioxide (EtCO₂), are assessed at predefined stages of the procedure: five minutes after induction of anesthesia, fifteen minutes after carbon dioxide insufflation in the Trendelenburg position, and ten minutes after carbon dioxide desufflation. Measurements are obtained using the integrated monitoring system of the anesthesia workstation.

The study aims to evaluate the physiological effects of the two ventilation strategies during laparoscopic surgery and determine whether either approach offers advantages in maintaining respiratory mechanics and adequate ventilation. The findings may contribute to evidence-based selection of mechanical ventilation strategies for patients undergoing elective laparoscopic cholecystectomy.

Studietype

Intervensjonell

Registrering (Faktiske)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Punjab Province
      • Multan, Punjab Province, Pakistan, 00000
        • Nishtar Medical University and Hospital, Multan

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

25 år til 50 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adult patients aged 25-50 years.
  • Either sex.
  • ASA physical status I or II.
  • Scheduled for elective laparoscopic cholecystectomy under general anaesthesia.
  • Written informed consent obtained.

Exclusion Criteria:

  • ASA physical status III or IV.
  • Body mass index (BMI) greater than 35 kg/m².
  • Significant pulmonary disease (e.g., COPD, asthma, restrictive lung disease).
  • Significant cardiovascular disease.
  • Pregnancy.
  • Previous upper abdominal surgery.
  • Conversion to open cholecystectomy.
  • Refusal to participate.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Volume Controlled Ventilation

Participants receive volume-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.

Mechanical ventilation delivered using the volume-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Ventilation is provided with a tidal volume of 8 mL/kg, respiratory rate adjusted to maintain end-tidal carbon dioxide between 32 and 38 mmHg, PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.

Eksperimentell: Pressure Controlled Ventilation

Participants receive pressure-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.

Mechanical ventilation delivered using the pressure-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia. Inspiratory pressure is adjusted to achieve a tidal volume of 8 mL/kg while maintaining end-tidal carbon dioxide between 32 and 38 mmHg, with PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Static Lung Compliance
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of static lung compliance between the volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) groups during elective laparoscopic cholecystectomy under general anesthesia.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
End-Tidal Carbon Dioxide (EtCO₂)
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of end-tidal carbon dioxide (EtCO₂) levels between the VCV and PCV groups.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Peak Inspiratory Pressure
Tidsramme: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Comparison of peak inspiratory pressure between the VCV and PCV groups during laparoscopic cholecystectomy.

Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. januar 2026

Primær fullføring (Faktiske)

30. juni 2026

Studiet fullført (Faktiske)

20. juli 2026

Datoer for studieregistrering

Først innsendt

8. juli 2026

Først innsendt som oppfylte QC-kriteriene

11. juli 2026

Først lagt ut (Faktiske)

16. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

13. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared because no formal data-sharing plan has been established. Participant confidentiality and institutional ethical requirements will be maintained.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere